The bars show 95 percent confidence intervals. Table 1 Risk of Progression among 1384 Residents of Southeastern Minnesota in Whom Monoclonal Gammopathy of Undetermined Significance was Diagnosed ...

Progression-free survival was measured from ... to follow-up to the status of having died (hazard ratio, 0.68; P=0.02) (Table S4 in the Supplementary Appendix). Multivariable analyses of overall ...

Table 1. Immune-Specific Related Response Criteria In March ... but iUPD must be confirmed to be considered true progression (iCPD); also a repeat scan must be performed at least 4 weeks, but not more ...

Table 1 Prospective observational studies investigating emerging risk factors and markers for CKD progression * This Review focuses on possible risk factors and markers of CKD progression for ...

Table 4. Summary of Treatment-Related Adverse Events in All Treated Patients and 5-Year Survivors Two of the 16 5-year survivors were treated with nivolumab beyond disease progression. One of the two ...

(Table 2). Monosomy 13/del(13q) had no impact on risk of progression. Similar results have also been reported by Neben et al. 10 in a study of 248 patients with SMM. Del(17p13), t(4;14) and gain ...

This progression is associated with impaired health ... to preserving kidney function and delaying disease progression (Table 1 8,19,22). A series of smaller clinical trials have suggested that ...